Indicators

Markets:

News

Latest News about psilocybin therapy

Recent news which mentions psilocybin therapy

Kaya Holdings Advocates For Psilocybin As FDA Rejects MDMA For PTSD Treatment

August 14, 2024

Utah Hospitals Will Soon Provide Psilocybin And MDMA Therapy For Mental Health Conditions

March 25, 2024

Psyched: New Evidence Shows Psilocybin As Anxiety Therapy, Open-Source Learning For Therapists, Enveric's Licensing Deals And More

March 04, 2024

Washington Doctor Vs. DEA For Lawful Use Of Psilocybin To Treat Terminally Ill Patients

February 14, 2024

Canadian At-Home Microdose Psilocybin Clinical Trial Finalized, Here Are The Details

March 31, 2023

Meth Use Disorder Tackled With Psilocybin: Clinical Trial Begins Patient Enrollment

March 28, 2023

Canada's Ongoing Struggle For Access To Natural Psilocybin As A Therapeutic Nabs Business Support

February 15, 2023

Canadian Psychedelics Company Launches Take-Home Psilocybin Trial For Some 300 Participants

February 01, 2023

Virginia Psychedelics: Legalizing Medical Use Of Psilocybin Gets A Thumbs Down

January 20, 2023

2023 Could Be Make Or Break For Psychedelics In Missouri, This GOP Lawmaker Is Pushing For Change

January 09, 2023

What Happened With Psychedelics In The Last Year? 11 Key News Items, The Sector's Performance & Takeaways

January 03, 2023

Oregon's Final Rules For Psilocybin Services Are Ready, Learn What To Expect

December 28, 2022

First-Ever Clinical Trial On Magic Mushroom Therapy For Autism's Genetic Cause Receives Approval

December 27, 2022

Canada: Fed Guidelines For Psychedelic Therapy, Quebec Treatment Costs, Access And Magic Mushrooms Dispensaries

December 21, 2022

Potential Road To At-Home Psychedelics Use Permits: Low Dosing's Positive Outcomes In Phase 1 Trial

December 12, 2022

Magic Mushrooms Tested For Treating Type II Bipolar Disorder, Check Out Results So Far

December 12, 2022

DEA's Consistent Denial Of Psilocybin Access For Terminally Ill Being Challenged Again

October 27, 2022

In Oregon You Can Get Trained To Be A Licensed Psilocybin Therapy Provider

October 07, 2022

Cannabis & Psychedelics As Effective Adjunct Medicine To Breast Cancer Therapy? Studies Say Yes

September 30, 2022

Why Magic Mushrooms Are Emerging As Major Part Of Public Discourse: What Science Is Saying

September 22, 2022

Why Magic Mushrooms Are Emerging As Major Part Of Public Discourse: The Legal Situation

September 19, 2022

Major Psychedelics Firm Is Studying Magic Mushrooms To Treat Meth Addiction

September 16, 2022

Mindset Pharma Meets With UK Regulator: Is A Phase 1 Trial Getting Close?

September 14, 2022

Psychedelics Companies Are Teaming Up To Offer Access Veterans

September 13, 2022

Cathie Wood's Psychedelics Fund ARK Analyzes The Sector's Present & Future And Likes What It Sees

September 06, 2022

Study Finds Psilocybin Anti-Depression Effects Last At Least One Year

March 04, 2022

The Case For Psilocybin Therapy And Depression

January 30, 2022

ATAI Life Sciences Announces New Program To Discover Next-Generation Mental Health Treatments

January 27, 2022

Psilocybin Therapy Combined With SSRI Antidepressants Is Possible, COMPASS Study Confirms

December 13, 2021

Peter Thiel-Backed Psychedelic Start-Up, ATAI Life Sciences, Increases Stake In Compass Pathways

November 29, 2021

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

© 2025 FinancialContent. All rights reserved.